Cartesian Therapeutics, Inc.
RNAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001453687
No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Cartesian Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 103 | 1 | 106 | +4 |
| Shares | 51.9M | 1.83M | 57.1M | +7.01M (+14.0%) |
| Value | $216.7M | $7.61M | $185.7M | −$23.4M (−11.2%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| NanoDimension, Inc. | 3,647,907 | $11.9M | 10.66% |
| Marshall Wace, LLP | 1,991,588 | $6.49M | 0.01% |
| Erste Asset Management GmbH | 1,210,000 | $4.04M | 0.07% |
| OUP Management Co., LLC | 862,543 | $2.81M | 1.27% |
| Ameriprise Financial Inc | 290,918 | $949.0K | 0.00% |
| Wellington Management Group LLP | 153,654 | $501.0K | 0.00% |
| HRT Financial LP | 148,353 | $483.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 140,045 | $456.0K | 0.00% |
| Qube Research & Technologies Ltd | 66,154 | $216.0K | 0.00% |
| Group One Trading, L.P. | 55,835 | $182.0K | 0.00% |
| Jump Financial, LLC | 42,600 | $139.0K | 0.01% |
| XTX Topco Ltd | 33,600 | $110.0K | 0.06% |
| Aristides Capital LLC | 29,000 | $95.0K | 0.05% |
| State of Wyoming | 27,678 | $90.0K | 0.04% |
| Blair William & Co | 14,950 | $49.0K | 0.00% |
| Squarepoint Ops LLC | 15,156 | $49.0K | 0.00% |
| Boothbay Fund Management, LLC | 12,019 | $39.0K | 0.00% |
| Credit Suisse AG | 11,666 | $37.0K | 0.00% |
Sold out (14)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Acuta Capital Partners, LLC | 1,024,668 | $4.26M |
| Bank of Montreal | 609,507 | $2.69M |
| Arrowstreet Capital, Limited Partnership | 185,839 | $773.0K |
| Alps Advisors Inc | 141,050 | $587.0K |
| Opaleye Management Inc. | 106,000 | $441.0K |
| Norges Bank | 99,400 | $414.0K |
| Capital Fund Management S.A. | 63,176 | $262.8K |
| Prudential Financial Inc | 41,740 | $174.0K |
| HighVista Strategies LLC | 22,269 | $92.0K |
| Beacon Pointe Advisors, LLC | 19,000 | $79.0K |
| Parametric Portfolio Associates LLC | 18,570 | $77.0K |
| Advisory Services Network, LLC | 10,000 | $42.0K |
| Penserra Capital Management LLC | 2,630 | $10.0K |
| Ellevest, Inc. | 50 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 1,828,025 | $7.61M |